Market News
Smart Trading. Simplified.
Tiny Biotech Wins $75 Billion Patent
Cambridge firm proves its possible to "Find & Replace" cancer cells. The Wall Street Journal reports this small biotech is "Transforming Medicine." No wonder Goldman Sachs & Morgan Stanley have been quietly buying shares.
Get the name of this little-known stock here >>>
5 Ways to Retire At 30
Most people spend don’t retire until they reach their mid-60s. To make matters even worse, the average retirement age keeps getting older. Between 2004 and 2010, most people retired around age 60. As recently as 2018, though, most Americans said that they didn’t plan to retire until age 66. Is it even possible to retire […]
Our #1 Investment of 2021
In August 2019, a small firm won a contract from the US Army to build a strange new weapon. When it starts producing this amazing weapon in scale later this year, the company could multiply its revenue 1,632-fold.
Our research proves that anyone who gets in now could profit 8990% >>>
Resideo Technologies Investment Thesis
Resideo Technologies, Inc. [NYSE: REZI] develops, manufactures, and sells home comfort and security solutions, including smart thermostats, security cameras and more, primarily in residential environments. REZI became an independent, publicly traded company in late 2018 as a result of Honeywell spinning off its Homes product portfolio and ADI Global Distribution businesses. The company’s products are […]
Investors Get Green-Light On Wall Street's Hidden $2 Uranium Stock
Why work for a living when you can retire immensely wealthy with just a few well-timed stock picks. Your neighbors are doing it, so why shouldn't you? Here's one you'll soon be bragging about, but you need to buy it first. It's the only Green-Energy stock that's positioned for 10X to 20X gains in Biden's Clean Energy Mandate.
Act fast and you'll be in below $2 per share.
The Bull Case For Bank of America
The Bank of America Corporation (BAC) recently surprised the market by missing its revenue expectations for the second quarter 2021. This in itself was unusual, but for a company whose stability attracted even Warren Buffett enough to become one of its largest shareholders, a miss such as this could have had investors re-examining whether the […]
Smart, Low-Risk Investing For Retirement
Gold IRAs are one of the many low-risk ways you can invest as a senior, offering an opportunity to both protect and grow your earnings. We will show you how you can roll over your IRA or 401(k) into precious metals. Tax free & penalty-free into an IRA holding using a loophole the IRS doesn't want you to know!
Get your free gold investing guide here!
Will Tesla Stock Go Up After Earnings?
Tesla’s last earnings report was something special to behold. The company’s stock has been pretty tumultuous over the past six months or so, seeming to trend downwards just as often as it trends upwards, so is it possible Tesla will go up after earnings next? The Bull Case For Tesla As one of the largest […]
The $62.7 Billion Memory-Saving Market
15.8 million people suffer from Alzheimer's, Parkinson's or ALS. But one little-known biotech is at the forefront revolutionizing this expected $62.7 billion market.
Invest alongside Jeff Bezos, Goldman Sachs, and BlackRock in what The Economist is calling "A Boon to Humanity."
Click here to be a part of it >>>
The Bull Case For Zillow
Zillow (Z), the popular online real estate marketplace company has grown quite substantially in market capitalization over recent quarters, and this trend only continued with the release of its most recent quarterly earnings. But just how substantial was that growth? Enough to confidently make the bull case for Zillow below. Zillow EPS Surprise To The […]
The $62.7 Billion Medical "Gold Rush"
A small San Francisco company holds the secret to a medical breakthrough The Economist called "A Boon to Humanity?"
Jim Cramer says it would be "The Biggest Drug Ever."
And our research proves that anyone who gets in now could profit 8990%
Click Here to Learn How >>>
View this email online if it doesn't display correctly. This newsletter is not financial advice. Please read our Disclaimer.
To unsubscribe from Financhill, click here.
PO Box 126
Catasauqua, PA 18032
Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.
The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The Financhill.com educational training program and software services are provided to improve financial understanding.
The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.
Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.
No comments:
Post a Comment